Shi P - Search Results

1

Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition.

Zha J, Chen F, Dong H, Shi P, Yao Y, Zhang Y, Li R, Wang S, Li P, Wang W, Xu B. Zha J, et al. Among authors: shi p. J Transl Med. 2014 Jun 11;12:163. doi: 10.1186/1479-5876-12-163. J Transl Med. 2014. PMID: 24915933 Free PMC article.

2

Utility of FDG PET/CT in guiding antifungal therapy in acute leukemia patients with chronic disseminated candidiasis.

Xu B, Shi P, Wu H, Guo X, Wang Q, Zhou S. Xu B, et al. Among authors: shi p. Clin Nucl Med. 2010 Aug;35(8):567-70. doi: 10.1097/RLU.0b013e3181e4db84. Clin Nucl Med. 2010. PMID: 20631500

3

Disulfiram/copper complex activated JNK/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells.

Xu B, Shi P, Fombon IS, Zhang Y, Huang F, Wang W, Zhou S. Xu B, et al. Among authors: shi p. Blood Cells Mol Dis. 2011 Dec 15;47(4):264-9. doi: 10.1016/j.bcmd.2011.08.004. Epub 2011 Sep 10. Blood Cells Mol Dis. 2011. PMID: 21911303

4

shRNA-Mediated BAALC knockdown affects proliferation and apoptosis in human acute myeloid leukemia cells.

Xu B, Chen G, Shi P, Guo X, Xiao P, Wang W, Zhou S. Xu B, et al. Among authors: shi p. Hematology. 2012 Jan;17(1):35-40. doi: 10.1179/102453312X13221316477499. Hematology. 2012. PMID: 22549446 Free article.

5

Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression.

Shi P, Zha J, Guo X, Chen F, Fan Z, Huang F, Meng F, Liu X, Feng R, Xu B. Shi P, et al. Pharmacogenomics. 2013 Jan;14(1):17-23. doi: 10.2217/pgs.12.182. Pharmacogenomics. 2013. PMID: 23252945

6

Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2.

Chen F, Liu Y, Wang S, Guo X, Shi P, Wang W, Xu B. Chen F, et al. Among authors: shi p. Pharmacogenomics. 2013 Aug;14(11):1305-17. doi: 10.2217/pgs.13.122. Pharmacogenomics. 2013. PMID: 23930677

7

Low MDR1 and BAALC expression identifies a new subgroup of intermediate cytogenetic risk acute myeloid leukemia with a favorable outcome.

Guo X, Shi P, Chen F, Zha J, Liu B, Li R, Dong H, Zheng H, Xu B. Guo X, et al. Among authors: shi p. Blood Cells Mol Dis. 2014 Sep;53(3):144-8. doi: 10.1016/j.bcmd.2014.05.001. Epub 2014 May 20. Blood Cells Mol Dis. 2014. PMID: 24855032

8

Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.

Zhao H, Shi P, Deng M, Jiang Z, Li Y, Kannappan V, Wang W, Li P, Xu B. Zhao H, et al. Among authors: shi p. Oncotarget. 2016 Dec 20;7(51):85515-85528. doi: 10.18632/oncotarget.13454. Oncotarget. 2016. PMID: 27888802 Free PMC article.

9

Allogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia.

Wang Y, Chen G, Cao R, Li J, He L, Guo X, Liang J, Shi P, Zhou Y, Xu B. Wang Y, et al. Among authors: shi p. Pharmacogenomics. 2017 Jan;18(1):77-84. doi: 10.2217/pgs-2016-0075. Epub 2016 Dec 14. Pharmacogenomics. 2017. PMID: 27967319

10

High BCL11A Expression in Adult Acute Myeloid Leukemia Patients Predicts a Worse Clinical Outcome.

Dong H, Shi P, Zhou Y, Yu Y, Guo X, Yao Y, Liu P, Xu B. Dong H, et al. Among authors: shi p. Clin Lab. 2017 Jan 1;63(1):85-90. doi: 10.7754/Clin.Lab.2016.160614. Clin Lab. 2017. PMID: 28164500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,016 results

Search Page

Filters